VIMC [Vimicro International] SC 13D/A: (Original Filing)

[PURCHASE AND SALE AGREEMENT Agreement Company Schedule 1 Seller Sellers Schedule 1.01(c) Ordinary Shares Schedule 1.01(c) ADSs Securities SECTION I PURCHASE AND SALE OF SECURITIES Sale of Securities 1.01 Schedule 1.01(a) First Tranche Ordinary Shares Schedule 1.01(a) First Tranche ADSs Schedule 1.01(b) Second Tranche Ordinary Shares Schedule 1.01(b) Second Tranche ADSs Purchase Price 1.02 Schedule 1.01(a) Schedule 1.01(b) Ordinary Share] [SCHEDULE 13D (AMENDMENT NO. 3) VIMICRO INTERNATIONAL CORPORATION (Name of Issuer) ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 92718N109** (CUSIP Number) THOMAS J. MURPHY C/O GENERAL ATLANTIC SERVICE COMPANY, LLC 55 East 52nd Street, 32nd Floor New York, NY 10055 (212) 715-4000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)]

By | 2016-03-31T17:51:40+00:00 December 19th, 2013|Categories: Chinese Stocks, SEC Original, VIMC|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] S-3: (Original Filing)

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 2834 (Primary Standard Industrialde Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The Peoples Republic of China, 712046 011-86-29-33686638 (Address,luding zipde, and telephone number,] [BIOSTAR PHARMACEUTICALS, TO TRUSTEE INDENTURETED OF , 20 SENIOR DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 8 SECTION1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8 SECTION1.4 ACTS OF HOLDERS; RECORDTES] [BIOSTAR PHARMACEUTICALS, TO TRUSTEE INDENTURETED OF , 20 SUBORDINATED DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10 SECTION 1.4 ACTS OF HOLDERS; RECORDTES] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong December 19, 2013 EX-23.1 ex23-1.htm 4 EX-23.1] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong December 19, 2013 EX-23.2 ex23-2.htm 5 EX-23.2]

By | 2016-02-07T15:00:18+00:00 December 19th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

SMI [SEMICONDUCTOR MANUFACTURING INTERNATIONAL] CORRESP: (Original Filing)

[December 19, 2013 VIA EDGAR Attention: Kevin L. Vaughn, Accounting Branch Chief Martin James, Senior Assistant Chief Accountant Eric Atallah, Staff Accountant Re: Semiconductor Manufacturing International Corporation Form 20-F for the Fiscal Year Ended December 31, 2012 Filed April 15, 2013 File No. 001-31994 Ladies and Gentlemen: Company Staff Commission Comment Letter Semiconductor Manufacturing International Corporation (the “ Form 20-F]

By | 2016-03-08T14:03:04+00:00 December 19th, 2013|Categories: Chinese Stocks, SEC Original, SMI|Tags: , , , , , |0 Comments

VIMC [Vimicro International] SC 13D/A: PURCHASE AND SALE AGREEMENT Agreement Company Schedule 1

[PURCHASE AND SALE AGREEMENT Agreement Company Schedule 1 Seller Sellers Schedule 1.01(c) Ordinary Shares Schedule 1.01(c) ADSs Securities SECTION I PURCHASE AND SALE OF SECURITIES Sale of Securities 1.01 Schedule 1.01(a) First Tranche Ordinary Shares Schedule 1.01(a) First Tranche ADSs Schedule 1.01(b) Second Tranche Ordinary Shares Schedule 1.01(b) Second Tranche ADSs Purchase Price 1.02 Schedule 1.01(a) Schedule 1.01(b) Ordinary Share] [SCHEDULE 13D (AMENDMENT NO. 3) VIMICRO INTERNATIONAL CORPORATION (Name of Issuer) ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 92718N109** (CUSIP Number) THOMAS J. MURPHY C/O GENERAL ATLANTIC SERVICE COMPANY, LLC 55 East 52nd Street, 32nd Floor New York, NY 10055 (212) 715-4000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)]

By | 2016-03-31T17:53:02+00:00 December 19th, 2013|Categories: Chinese Stocks, VIMC, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] S-3: FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 2834 (Primary Standard Industrialde Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The Peoples Republic of China, 712046 011-86-29-33686638 (Address,luding zipde, and telephone number,] [BIOSTAR PHARMACEUTICALS, TO TRUSTEE INDENTURETED OF , 20 SENIOR DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 8 SECTION1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8 SECTION1.4 ACTS OF HOLDERS; RECORDTES] [BIOSTAR PHARMACEUTICALS, TO TRUSTEE INDENTURETED OF , 20 SUBORDINATED DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10 SECTION 1.4 ACTS OF HOLDERS; RECORDTES] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong December 19, 2013 EX-23.1 ex23-1.htm 4 EX-23.1] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong December 19, 2013 EX-23.2 ex23-2.htm 5 EX-23.2]

By | 2016-02-07T15:00:53+00:00 December 19th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

SMI [SEMICONDUCTOR MANUFACTURING INTERNATIONAL] CORRESP: December 19, 2013 VIA EDGAR Attention: Kevin L.

[December 19, 2013 VIA EDGAR Attention: Kevin L. Vaughn, Accounting Branch Chief Martin James, Senior Assistant Chief Accountant Eric Atallah, Staff Accountant Re: Semiconductor Manufacturing International Corporation Form 20-F for the Fiscal Year Ended December 31, 2012 Filed April 15, 2013 File No. 001-31994 Ladies and Gentlemen: Company Staff Commission Comment Letter Semiconductor Manufacturing International Corporation (the “ Form 20-F]

By | 2016-03-08T14:04:12+00:00 December 19th, 2013|Categories: Chinese Stocks, SMI, Webplus ver|Tags: , , , , , |0 Comments

VIMC [Vimicro International] 6-K: (Original Filing)

[Vimicro Enters into Share Repurchase Transaction BEIJING, December 18, 2013 — Vimicro International Corporation (VIMC) (“Vimicro” or the “Company”), a leading video processing IC and surveillance solution provider, today announced that it has entered into a purchase and sale agreement (the “Agreement”) with General Atlantic investment funds (“General Atlantic”) to repurchase ordinary shares and ADSs (the “Securities”) held by General] [VIMICRO INTERNATIONAL CORPORATION 15/F Shining Tower Form 20-F x Form 40-F o o o VIMICRO INTERNATIONAL CORPORATION John Zhonghan Deng Chairman and Chief Executive Officer]

By | 2016-03-31T17:54:17+00:00 December 19th, 2013|Categories: Chinese Stocks, SEC Original, VIMC|Tags: , , , , , |0 Comments

SMI [SEMICONDUCTOR MANUFACTURING INTERNATIONAL] 20-F/A: (Original Filing)

[FORM 20-F/A (Amendment No. 1) o OR x OR o OR o Semiconductor Manufacturing International Corporation N/A Cayman Islands (Jurisdiction of incorporation or organization) 18 Zhangjiang Road, Pudong New Area, Shanghai, China 201203 The People’s Republic of China Mr. Gareth Kung, Chief Financial Officer Telephone: (8621) 3861-0000 Facsimile: (8621) 3895-3568 18 Zhangjiang Road, Pudong New Area, Shanghai, China 201203 (Name,] [Certification I, Tzu-Yin Chiu, certify that: 1. I have reviewed this annual report on Form 20-F/A of Semiconductor Manufacturing International Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Gareth Kung, certify that: 1. I have reviewed this annual report on Form 20-F/A of Semiconductor Manufacturing International Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Dr. Tzu-Yin Chiu Chief Executive Officer and Executive Director Gareth Kung Chief Financial Officer EX-13.1 4 a13-26516_1ex13d1.htm EX-13.1]

By | 2016-03-08T14:05:45+00:00 December 19th, 2013|Categories: Chinese Stocks, SEC Original, SMI|Tags: , , , , , |0 Comments

VIMC [Vimicro International] 6-K: Vimicro Enters into Share Repurchase Transaction BEIJING, December

[Vimicro Enters into Share Repurchase Transaction BEIJING, December 18, 2013 — Vimicro International Corporation (VIMC) (“Vimicro” or the “Company”), a leading video processing IC and surveillance solution provider, today announced that it has entered into a purchase and sale agreement (the “Agreement”) with General Atlantic investment funds (“General Atlantic”) to repurchase ordinary shares and ADSs (the “Securities”) held by General] [VIMICRO INTERNATIONAL CORPORATION 15/F Shining Tower Form 20-F x Form 40-F o o o VIMICRO INTERNATIONAL CORPORATION John Zhonghan Deng Chairman and Chief Executive Officer]

By | 2016-03-31T17:55:17+00:00 December 19th, 2013|Categories: Chinese Stocks, VIMC, Webplus ver|Tags: , , , , , |0 Comments

SMI [SEMICONDUCTOR MANUFACTURING INTERNATIONAL] 20-F/A: FORM 20-F/A (Amendment No. 1) o OR x

[FORM 20-F/A (Amendment No. 1) o OR x OR o OR o Semiconductor Manufacturing International Corporation N/A Cayman Islands (Jurisdiction of incorporation or organization) 18 Zhangjiang Road, Pudong New Area, Shanghai, China 201203 The People’s Republic of China Mr. Gareth Kung, Chief Financial Officer Telephone: (8621) 3861-0000 Facsimile: (8621) 3895-3568 18 Zhangjiang Road, Pudong New Area, Shanghai, China 201203 (Name,] [Certification I, Tzu-Yin Chiu, certify that: 1. I have reviewed this annual report on Form 20-F/A of Semiconductor Manufacturing International Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Gareth Kung, certify that: 1. I have reviewed this annual report on Form 20-F/A of Semiconductor Manufacturing International Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Dr. Tzu-Yin Chiu Chief Executive Officer and Executive Director Gareth Kung Chief Financial Officer EX-13.1 4 a13-26516_1ex13d1.htm EX-13.1]

By | 2016-03-08T14:06:36+00:00 December 19th, 2013|Categories: Chinese Stocks, SMI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar